ResMed, Inc. (RMD)
239.53
+0.64
(+0.27%)
USD |
NYSE |
Nov 13, 16:00
239.53
0.00 (0.00%)
After-Hours: 19:59
ResMed Price to Book Value : 5.664 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 5.649 |
| November 11, 2026 | 5.640 |
| November 10, 2026 | 5.536 |
| November 09, 2026 | 5.574 |
| November 06, 2026 | 5.564 |
| November 05, 2026 | 5.659 |
| November 04, 2026 | 5.687 |
| November 03, 2026 | 5.370 |
| November 02, 2026 | 5.508 |
| October 30, 2026 | 5.437 |
| October 29, 2026 | 5.978 |
| October 28, 2026 | 5.916 |
| October 27, 2026 | 5.930 |
| October 26, 2026 | 5.987 |
| October 23, 2026 | 5.979 |
| October 22, 2026 | 5.984 |
| October 21, 2026 | 5.822 |
| October 20, 2026 | 5.805 |
| October 19, 2026 | 5.670 |
| October 16, 2026 | 5.651 |
| October 15, 2026 | 5.728 |
| October 14, 2026 | 5.564 |
| October 13, 2026 | 5.558 |
| October 12, 2026 | 5.547 |
| October 09, 2026 | 5.440 |
| Date | Value |
|---|---|
| October 08, 2026 | 5.361 |
| October 07, 2026 | 5.344 |
| October 06, 2026 | 5.218 |
| October 05, 2026 | 5.270 |
| October 02, 2026 | 5.176 |
| October 01, 2026 | 5.229 |
| September 30, 2026 | 5.228 |
| September 29, 2026 | 4.881 |
| September 28, 2026 | 4.865 |
| September 25, 2026 | 4.862 |
| September 24, 2026 | 4.86 |
| September 23, 2026 | 4.869 |
| September 22, 2026 | 4.862 |
| September 21, 2026 | 4.898 |
| September 18, 2026 | 4.928 |
| September 17, 2026 | 5.003 |
| September 16, 2026 | 4.999 |
| September 15, 2026 | 5.025 |
| September 14, 2026 | 4.884 |
| September 11, 2026 | 4.781 |
| September 10, 2026 | 4.810 |
| September 09, 2026 | 4.818 |
| September 08, 2026 | 4.842 |
| September 04, 2026 | 5.002 |
| September 03, 2026 | 5.020 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Accuray, Inc. | 0.1587 |
| Orthofix Medical, Inc. | 0.6811 |
| Rockwell Medical, Inc. | 0.8403 |
| Microbot Medical, Inc. | 0.9497 |
| Stereotaxis, Inc. | 3.918 |
Price to Book Value Related Metrics
| PE Ratio | 21.81 |
| PS Ratio | 6.064 |
| PEG Ratio | 1.762 |
| Price to Free Cash Flow | 21.88 |
| Price | 239.53 |
| Earnings Yield | 4.58% |
| Market Cap | 33.69B |
| PEGY Ratio | 1.624 |
| Operating PE Ratio | 17.87 |
| Normalized PE Ratio | 21.59 |